Equity
€5.1m ▲ 0.6%
Novitan has made a profit in every financial year since 2007.
Novitan
Lifetime
20 annual accounts with figures on one time axis, 34 filings since 1993peak €9.8m (2021)
€4.2m▼ 12.5%
peak €6.9m (2021)
€2.3m▼ 23.3%
peak €5.3m (2013)
€5.1m▲ 0.6%
€25.1m▲ 466%
peak 15.5 FTE (2026)
15.5 FTE▲ 20.2%
Board7 names since 2015
2 directorsOxico and 1 other
Owners3 names in the annual accounts
Documentsfilings and deeds
27-10-20264 days before the deadline
2026financial year
Gross margin from €4.8m to €4.2mStaff from 12.9 FTE to 15.5 FTEDividend €1.0mDebts from €4.4m to €25.1mInvestments €376,934
Key points
from the 2026 annual accountsTurnover
≈ €18.0m estimated
The accounts state no turnover.
Debts
€25.1m 83% of the balance sheet
Financial debts 25%Suppliers 65%Taxes and wages 1%Other 9%
€6.9m of the debts are secured on the company's own assets.
Investments
€381,050 2.1 × depreciation
Green is investment, beige is depreciation.
Staff
18 employees on 31-03-2026
In 2026, 7 people joined and 6 left.
Position in the sector
16.8%
Lower solvency than 82% of companies in wholesale trade. Sector median 47.6% · 445 companies.
Checked score
85
Excellent
Financially stronger than 39% of small companies in wholesale trade (NACE 46)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 4,374 companies (NACE 46, small).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.4%▲ +0.2 percentage points vs 10-2025highest value
12-2025: < 0.1%▼ -0.4 percentage points vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026lowest value
04-2026: < 0.1%● unchanged vs 03-2026lowest value
05-2026: < 0.1%● unchanged vs 04-2026lowest value
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: 0.3%▲ +0.3 percentage points vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Equity €5.1m (16.8% of total assets)
Liquidity: current ratio 1.56, cash €1.6m
Sector: Wholesale trade (NACE 46)
lowers risk
Legal form: public limited company
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 19% of them on solvency, 22% on liquidity, 79% on profitability and 37% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-03-2026.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,613 companies had the same profile as Novitan has now. Each dot stands for 7 companies, two years later.
97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of Novitan itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,613 companies, not a prediction for Novitan. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €430,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.56 (1.96 in 2025), above the usual 1.5. Short-term debt is 62% and cash 5.5% of total assets. However, 83.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 445 sector peers (2026).
NBB · sector comparisonPosition among 445 sector peers
Solvency
better than 17%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 27-10-2026, 4 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2026
4 days early
2025
on the day
2024
2 days early
2023
on the day
2022
7 days late
2021
5 days late
2020
27 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 5 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 31 October (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-03-2027 year end31-10-2027 deadline
Recent changes
Registered office moved from Moorslede to Kortrijk
New registered office: Evolis 29, 8500 Kortrijk · Previous registered office: Beselarestraat 72, 8890 Moorslede · Permanent representative: Thomas Ockier · Board meeting of 17-03-2021 · Gazette deed
1 director appointed, 1 resignation, 1 reappointment
Resignation: Delphine Valcke (managing director) · Appointment: VALOC (managing director) · Permanent representatives: Delphine Valcke and Thomas Ockier · General meeting of 01-01-2021 · Gazette deed
Company renamed from Andacon to Novitan
Appointment: Valcke, Delphine Marie Paul (day-to-day manager) · Permanent representative: Ockier, Thomas Marcel Marc · General meeting of 16-05-2019 · Gazette deed
Resignation: Thomas Ockier (director)
Permanent representative: Thomas Ockier · General meeting of 08-10-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Novitan Kortrijk | €30.2m | €4.2m | 16.8% | 15.5 |
| RMS Medical Devices Roosdaal | €10.4m | €4.3m | 55.4% | 15.7 |
| HANDI-MOVE Ninove | €16.2m | €5.3m | 86.0% | 29 |
| BIOGNOST Kortrijk | €7.3m | €3.9m | 67.8% | 10.9 |
| KARL STORZ ENDOSCOPY BELGIUM Berchem-Sainte-Agathe | €7.7m | €4.0m | 14.3% | 18.3 |
| ALIVIRA Leuven | €8.2m | €5.8m | 51.5% | 11.3 |
| ANDOCOR Hoogstraten | €12.3m | €4.2m | 38.2% | 39.5 |
These companies have the same main activity as Novitan: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €7.3m and €16m, founded between 1982 and 1996.
Official details
Source: KBO- Status
- Active since 30-03-1992Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Joint committees
- 200Auxiliary committee for white-collar workers
- 116Chemical industry · annual accounts 31-03-2026
- Establishment unit
- 2.057.652.8828500 Kortrijk, since 18-12-2001
- Financial year end
- 31 March
- Peppol
- Reachable
Annual accounts to 31-03-2026
- €30.2m▲ 218%
- Employeeson 31-03-2026
- 18▲ 5.9%
- Filing
- Filed on 27-10-2026, 4 days before the end of the filing period
Companies linked to Novitan
Parent and group
Insights on Novitan
Novitan has existed since 1992. The gross margin grew from €2.1m in 2007 to €4.2m in 2026 and staff from 5.5 to 15.5 full-time equivalents.
Solvency fell in 2026 from 53.3% to 16.8% because of higher debts to suppliers.
Oxico holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Novitan
- What is the company number of Novitan?
- The company number of Novitan is 0446.988.767. The VAT number is the same number with BE in front: BE 0446.988.767.
- Where is Novitan based?
- The registered office is at Evolis 29, 8500 Kortrijk.Company details
- What does Novitan do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of Novitan?
- Novitan is a public limited company (NV).
- When was Novitan founded?
- Novitan was founded on 30-03-1992.
- Is Novitan still active?
- Yes, Novitan is an active enterprise in the KBO register.
- How many employees does Novitan have?
- Novitan had an average of 15.5 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does Novitan fall under?
- In its 31-03-2026 annual accounts, Novitan states joint committees 200 (Auxiliary committee for white-collar workers) and 116 (Chemical industry).
- What is the turnover of Novitan?
- The turnover in financial year 2026 is ≈ €18.0m. This figure is estimated from the gross margin of €4.2m and 98 comparable companies (NACE 46). It probably lies between €11.0m and €30.0m.
- Is Novitan profitable?
- In financial year 2026, Novitan made a profit of €2.3m.
- Where can I find the annual accounts of Novitan?
- Novitan filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of Novitan due?
- Novitan must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.